Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial-Reference-Cited by-同舟云学术

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Published:2009-06 Issue:9679 Volume:373 Page:1949-1957
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Muñoz Nubia,Manalastas Ricardo,Pitisuttithum Punee,Tresukosol Damrong,Monsonego Joseph,Ault Kevin,Clavel Christine,Luna Joaquin,Myers Evan,Hood Sara,Bautista Oliver,Bryan Janine,Taddeo Frank J,Esser Mark T,Vuocolo Scott,Haupt Richard M,Barr Eliav,Saah Alfred

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study;Woodman;Lancet,2001

2. High incidence of cervical human papillomavirus infection in women during their first sexual relationship;Collins;Br J Obstet Gynaecol,2002

3. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students;Winer;Am J Epidemiol,2003

4. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results;Munoz;J Infect Dis,2004

5. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis;de Sanjose;Lancet Infect Dis,2007

Cited by 411 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Our Daughters—Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali;Vaccines;2024-09-06

2. Exploration of individual socioeconomic and health-related characteristics associated with human papillomavirus vaccination initiation and vaccination series completion among adult females: A comprehensive systematic evidence review with meta-analysis;Vaccine;2024-09

3. Estimation of self‐funded human papillomavirus vaccine recipients from Japan's previously assumed “unvaccinated generation”;Cancer Science;2024-07-11

4. Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States;Preventive Medicine;2024-05

5. Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar;Women's Health;2024-01